Answers are grounded in this paper and cite their sources.
Nearly 2 years ago, President Bush declared 2002–2011 the National Bone and Joint Decade (http://www.boneandjointdecade.org/us), signaling America's entry into a global campaign to improve the quality of life for people with musculoskeletal conditions and to advance understanding and treatment through research, prevention, and education. The declaration of the Decade is indeed timely, because worldwide, musculoskeletal conditions affect hundreds of millions of people. Even more will be affected by 2020, when the number of people over the age of 50 is expected to double. In the United States each year, musculoskeletal conditions and injuries account for about 102.3 million visits to physicians' offices. In addition, one of two women and one of eight men over 50 will have an osteoporosis-related fracture. Musculoskeletal conditions are a leading cause of disability in the United States, and it is estimated that in 2000, they will cost the Nation up to $254 billion in medical expenses and lost productivity—a staggering burden. The Decade coincides with an extraordinarily exciting period for bone and joint research. The genetic/genomic revolution has given us fantastic tools and databases that will speed research and help us to understand the genetic factors that influence musculoskeletal health and disease. Powerful new imaging tools will let us delve more deeply into bone and joint health, so that we can better understand, track, treat, and prevent disease. Funding support from the Administration and Congress has been generous over the past years, allowing us to pursue large clinical research studies and trials that could never before have been possible. In addition to these, the high visibility for the musculoskeletal system afforded by Decade activities and the upcoming Surgeon General's Report on Osteoporosis and Bone Health (http://www.surgeongeneral.gov/topics/bonehealth/default.htm) create an atmosphere for making grand strides in research. Long a major contributor to research, training, and education in musculoskeletal conditions, the U.S. Department of Health and Human Services' National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)—along with other institutes and centers at the National Institutes of Health—is already reflecting this atmosphere of progress. The Institute, along with the National Institute on Aging, has been a prime force in developing the Osteoarthritis Initiative, an innovative public/private partnership that is developing a large research resource that will help identify biomarkers for this most common form of arthritis (http://www.niams.nih.gov/ne/oi/index.htm). NIAMS recently sponsored a Consensus Development Conference on total knee replacement (http://www.nih.gov/news/pr/dec2003/od-10a.htm). Thanks to generous funding increases, the Institute has been able to support large clinical trials assessing surgical interventions for various causes of low back pain (http://www.niams.nih.gov/ne/press/1999/09_20.htm) and various approaches to fracture repair techniques for long bones (http://www.niams.nih.gov/ne/press/2002/10_08.htm). New studies have been funded, and new energy is being expended to focus on the assessment of bone quality. However, the advent of the National Bone and Joint Decade offers us more than the opportunity to recount our present successes. It challenges us to (1) raise awareness about the growing burden of musculoskeletal disorders on society; (2) promote prevention and empower patients through educational programs; (3) advance research and training in prevention, diagnosis, and treatment; and (4) improve diagnostic and treatment options. And—as with all challenges—it presents obstacles that must be surmounted to achieve further success. First and foremost, we must build the number of physician-scientists conducting clinical research and address the shortage of physicians in the research pipeline. The National Institutes of Health's Loan Repayment Programs and clinical research career training and mentoring grants are steps in the right direction. We also need to nurture those already doing clinical research who are challenged by daunting clinical research oversight burdens and the task of carving out protected research time. Second, we need to ensure that we apply fundamental advances in cellular and molecular biology, immunology, genetics, and bioengineering to such clinically important areas as osteoporosis and osteoarthritis. To accomplish this, we need more scientists who can bridge the gap between bench and bedside. Third, we must do a better job of affecting the behavioral changes that will result in better bone and joint health. Osteoporosis, for example, may be more evident in older adults, but its seeds are sown in childhood, when adequate calcium deposits are not made in children's “bone banks.” It is particularly important that we extend prevention strategies to all people—regardless of age, gender, race, or socioeconomic condition—and deliver health messages in culturally sensitive and effective ways. The work that we do in musculoskeletal conditions is critically important. Although we begin the National Bone and Joint Decade with perhaps the greatest array of research tools ever known to man, true research success can only lie in a broad-based coalition of individuals and groups working together at international, national, regional, and local levels: patients and practitioners, researchers, voluntary and professional associations, and industry. Our efforts in areas such as communication, research, and education depend on these collaborative partnerships. Top leaders of the National Institutes of Health, the American Society for Bone and Mineral Research, the American College of Rheumatology, the Orthopaedic Research Society, the American Academy of Orthopaedic Surgeons, and the American College of Osteopathic Physicians, among others, have met—and will continue to meet—to develop and promote Decade initiatives. The Decade represents a unique opportunity to enhance the image of musculoskeletal medicine in the eyes of the public, policy makers, and the medical student population and to nurture an environment that will produce more musculoskeletal researchers and clinical scientists. Last year, a special feature on bone and cartilage was published by a leading journal (http://www.nature.com/nature/insights/6937.html), and an educational supplement for the Nation's middle schools is being developed. In the end, the ways we approach bone and joint research issues may evolve and change. However, our overall goal must remain the same: to advance the scientific enterprise so that no one lives with daily musculoskeletal pain or discomfort or the life-altering changes they can bring about.
No takes yet. Share an insight, caveat, or question.
Stephen I. Katz (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: